Amneal Receives U.S. FDA Approval for Memantine/Donepezil Extended-Release Capsules and Everolimus Tablets for Oral Suspension, and Tentative U.S. FDA Approval for Rifaximin
January 23, 2025 Approval of three important therapies for dementia, oncology and gastrointestinal disease Granted 180-day exclusivity for memantine/donepezil extended-release capsules Tentative approval of rifaximin, a product for treating IBS-D BRIDGEWATER, N.J.–Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”) today announced that the U.S. Food and Drug Administration (FDA) has approved memantine/donepezil 14-10 mg […]
Omnicell Announces OmniSphere
Next-generation, cloud native, software workflow engine and data platform intended to seamlessly integrate enterprise robotics and smart devices across the continuum of care Company Showcases New and Enhanced Outcomes-Centric Innovation at ASHP Midyear 2024 FORT WORTH, Texas– Omnicell, Inc. (Nasdaq:OMCL) (“Omnicell” or the “Company”), a leader in transforming the pharmacy and nursing care delivery model, […]
BOC Board Announces 2025 Executive Committee and New Members
BOC’s Board Chair Cameron Stewart, BOCO, BOCP (View/Download) OWINGS MILLS, Md. (Jan. 27, 2025) –The Board of Certification/Accreditation (BOC) proudly announces the Board of Directors’ 2025 Executive Committee, election of two new members and long-standing leader and Immediate Past Chairman, Wayne R. Rosen’s retirement. Members of the BOC Executive Committee for 2025 include: • Chairman: […]
ProxsysRx Announces Strategic Combination With Maxor National Pharmacy Services
Birmingham’s ProxsysRx has agreed to a strategic combination with Maxor National Pharmacy Services (“Maxor”), positioning the combined entity as the largest independent provider of pharmacy management services to health systems, hospitals, clinics, and other provider organizations. “I’m incredibly excited about this new chapter with Maxor,” said George Salem, CEO of ProxsysRx. “Our organizations have a […]
Endo Launches Doxycycline for Injection, USP
MALVERN, Pa., Dec. 10, 2024 /PRNewswire/ — Endo, Inc. (OTCQX: NDOI) announced today that it has begun shipping doxycycline for injection, USP 100 mg/vial, an AP-rated version of DOXY 100™. “We’re pleased to provide choices to healthcare providers and hospital pharmacies as they work to deliver quality patient care,” said Scott Sims, Senior Vice President […]
Amneal Resubmits DHE Autoinjector New Drug Application and Receives U.S. FDA Approval of Exenatide, its First Generic Injectable GLP-1 Agonist
November 21, 2024 Potential first and only DHE autoinjector for tough-to-treat migraines and cluster headaches Exenatide approval highlights Amneal’s capabilities in developing GLP-1 injectables BRIDGEWATER, N.J.–(BUSINESS WIRE)– Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”), a global pharmaceutical company, today announced the advancement of two key strategic initiatives. First, the Company has resubmitted to […]
Endo Receives U.S. FDA Approval of Manufacturing Facility in Indore, India
20,000-square-foot site increases Endo’s sterile injectable production capacity This marks the site’s first U.S. FDA approval Endo is investing and innovating in its Injectable Solutions business MALVERN, Pa., Dec. 9, 2024 /PRNewswire/ — Endo, Inc. (OTCQX: NDOI) announced today that the U.S. Food and Drug Administration (FDA) has approved commercial production of VASOSTRICT® (vasopressin injection, […]
Pharma Logistics and Rx Reverse Distributors Partner to Lead the Future of Compliance and Service
Libertyville, IL — Pharma Logistics, LLC and Rx Reverse Distributors, Inc., two leaders in the pharmaceutical reverse distribution industry, are excited to announce that they have joined forces, combining their expertise, resources, and shared vision to deliver unmatched value to customers. This collaboration marks a new chapter in the industry, offering enhanced service, innovative technology, […]
Endo Launches ADRENALIN® Ready-to-Use Premixed Bag, the First and Only FDA-Approved, Manufacturer-Prepared Epinephrine Premixed IV Bag
MALVERN, Pa., Dec. 2, 2024 /PRNewswire/ — Endo, Inc. (OTCQX: NDOI) announced today the launch of its ADRENALIN® (epinephrine in 0.9% sodium chloride injection) ready-to-use premixed bag, the first and only FDA-approved, manufacturer-prepared epinephrine premixed intravenous (IV) bag. “The first-ever ready-to-use epinephrine premixed bag represents an advancement for both providers and patients thanks to a […]
Kewaunee & NuAire: Market Leaders Join Forces to Revolutionize the Industry
We are thrilled to announce that NuAire has joined the Kewaunee Scientific Corporation family of companies. This partnership brings together two of the most renowned names in laboratory furnishings, combining world-class portfolios to create a powerhouse of innovation and expertise. Together, Kewaunee and NuAire offer a complete portfolio of furniture, fume hoods, biosafety cabinets, incubators […]
